289 related articles for article (PubMed ID: 20069648)
1. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
[TBL] [Abstract][Full Text] [Related]
2. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
3. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.
Bitzegeio J; Bankwitz D; Hueging K; Haid S; Brohm C; Zeisel MB; Herrmann E; Iken M; Ott M; Baumert TF; Pietschmann T
PLoS Pathog; 2010 Jul; 6(7):e1000978. PubMed ID: 20617177
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
5. Effect of cell polarization on hepatitis C virus entry.
Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
[TBL] [Abstract][Full Text] [Related]
6. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
Timpe JM; Stamataki Z; Jennings A; Hu K; Farquhar MJ; Harris HJ; Schwarz A; Desombere I; Roels GL; Balfe P; McKeating JA
Hepatology; 2008 Jan; 47(1):17-24. PubMed ID: 17941058
[TBL] [Abstract][Full Text] [Related]
9. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
[TBL] [Abstract][Full Text] [Related]
10. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
[TBL] [Abstract][Full Text] [Related]
11. Claudin association with CD81 defines hepatitis C virus entry.
Harris HJ; Davis C; Mullins JG; Hu K; Goodall M; Farquhar MJ; Mee CJ; McCaffrey K; Young S; Drummer H; Balfe P; McKeating JA
J Biol Chem; 2010 Jul; 285(27):21092-102. PubMed ID: 20375010
[TBL] [Abstract][Full Text] [Related]
12. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
13. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
[TBL] [Abstract][Full Text] [Related]
15. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
[TBL] [Abstract][Full Text] [Related]
17. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
18. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus entry into host cells.
Helle F; Dubuisson J
Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604
[TBL] [Abstract][Full Text] [Related]
20. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]